Qin has found through pharmacological studies that the key targets of Pachyman in the treatment of liver cancer include TNF, VEGFA, CASP3, ALB, SRC, etc. Molecular docking results showed that VEGFA and ALB may be the key targets of Pachyman in the treatment of liver cancer. The gene discussed is SRC; the disease is liver cancer.